We provide you with 20 years of free, institutional-grade data for INO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of INO. Explore the full financial landscape of INO stock.
| Reported Date | CIK | Ticker | Type |
|---|
Inovio Pharmaceuticals, Inc(NASDAQ:INO) 
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely design...
Website: http://www.inovio.com
Founded: 1999
Full Time Employees: 190
CEO: J. Joseph Kim
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about INO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.